SAIPARENT521.00

Sai Parenterals Limited

· Pharma & Health
₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,302 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SAIPARENT
FY26
INDOCO
FY26
PANACEABIO
FY26
HIKAL
FY26
Peer
Median
Valuation — at last close
P/E119.50×
P/B4.65×2.55×2.87×2.41×2.55× +82%
EV/EBITDA56.96×23.92×-501.02×16.16×16.16× +252%
Market Cap₹2,302 Cr₹2,381 Cr₹2,378 Cr₹2,891 Cr₹2,381 Cr -3%
Growth
Revenue CAGR 3Y3.41%11.63%-5.40%3.41%
Revenue CAGR 5Y8.25%0.47%-0.09%0.47%
Revenue YoY (latest Q)6.76%19.72%5.89%6.76%
Net Income YoY (latest Q)280.03%-44.44%66.96%66.96%
Profitability
EBITDA Margin10.16%7.68%-0.73%12.87%7.68% +32%
Net Income Margin3.74%-5.35%-1.12%-2.85%-2.85% +231%
Return on Common Equity2.88%-10.21%-0.65%-4.07%-4.07% +171%
Return on Capital Employed2.57%1.00%-4.13%3.36%1.00% +157%
Return on Assets1.00%-3.81%-0.57%-2.06%-2.06% +149%
Credit & Quality
Total Debt/Equity0.65×1.11×0.03×0.57×0.57× +14%
Interest Coverage1.18×0.13×-6.23×0.91×0.13× +808%
Scale — latest FY
Revenue / Total Income₹381 Cr₹1,845 Cr₹640 Cr₹1,713 Cr₹1,713 Cr -78%
Net Income₹14.3 Cr−₹98.7 Cr−₹7.2 Cr−₹48.8 Cr−₹48.8 Cr +129%
Total Assets₹1,424 Cr₹2,593 Cr₹1,262 Cr₹2,365 Cr₹2,365 Cr -40%
EPS₹4.36₹-10.7₹-0.88₹-3.96₹-3.96 +210%
Book Value per Share₹112.07₹100.99₹135.22₹97.07₹100.99 +11%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.